Xuesetong Tablets

This product can dilate coronary and peripheral blood vessels, reduce peripheral resistance, slow down heart rate, reduce and lower myocardial oxygen consumption, increase myocardial perfusion, increase cerebral blood flow, and has a certain improvement effect on myocardial and cerebral ischemia; it has the effect of significantly inhibiting platelet aggregation, reducing blood viscosity, and inhibiting thrombosis; in addition, this product also has the effects of lowering blood lipids, resisting fatigue, resistant to hypoxia, and improving and enhancing macrophage function.

The effective part of Panax notoginseng extracted from Panax notoginseng is mainly ginsenoside R, ginsenoside R, and ginsenoside R.

This product is a sugar-coated tablet. After removing the sugar coating, it appears white or slightly yellow. It tastes bitter and slightly sweet.

Oral administration: 50-100 mg at a time, three times a day.

According to monitoring, this product has caused 1 case of drug rash and 1 case of allergic purpura since it was approved for production and marketing on March 27, 1993.

Not yet clear.

Precautions during pregnancy and lactation: Use with caution in pregnant women.

Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.

seal.

Each tablet weighs 0.225g (containing 100mg of Panax notoginseng saponins)

Three years

KPC Xuesaitong Pharmaceutical Co., Ltd.

• Founded in:

  1998-12-05

• Address:

  No. 69, Jinyao Road, Xinhua Town, Funing County, Wenshan Prefecture, Yunnan Province

• Tax NO.:

  91530000218330862L

• Registered Funds:

  55.2 million yuan

• Email:

  Log in to view